Screener
KORU Medical Systems KRMD Research and development costs
Research and development costs at other companies
Other financials
Where this comes from
Reported directly by KORU Medical Systems in its filing.
Tagged under the XBRL concept us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment.
The source filing: KORU Medical Systems’s 10-K, filed March 12, 2026.
- Filed
- Mar 12, 2026, 4:09 PM EDT
- Fiscal year
- FY2026
- Accession
- 0001161697-26-000052
| Line item | December 31, 2025 | December 31, 2024 |
|---|---|---|
| Deferred Tax Assets: | ||
| Net Operating Loss | $4,984,118 | $4,025,905 |
| Credits | 113,204 | 129,598 |
| Capitalized Research Costs | 1,276,364 | 2,451,496 |
| NQO & RSA Stock Options | 517,418 | 350,484 |
| Deferred Lease Liability | 830,800 | 647,446 |
| Accruals & Reserves | 694,279 | 712,058 |
| Other | — | 48 |
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
FAQ
- What is KORU Medical Systems's research and development costs?
- KORU Medical Systems (KRMD) reported research and development costs of $1.28M in Q4 2025.
- What is the long-term trend for KORU Medical Systems's research and development costs?
- Over 2 years (2023 to 2025), KORU Medical Systems's research and development costs has grown at a -21.0% compound annual growth rate (CAGR), from $2.05M to $1.28M.
- What does research and development costs mean?
- Research and development costs as reported by KORU Medical Systems, Inc. Common Stock (DE).
Ask your AI about KORU Medical Systems's research and development costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude